JANSSEN-CILAG ΦΑΡΜΑKEYTIKH ΜΟΝΟΠΡΟΣΩΠΗ ΑΝΩΝΥΜΟΣ ΕΜΠΟΡΙΚΗ ΚΑΙ ΒΙΟΜΗΧΑΝΙΚΗ ΕΤΑΙΡΕΙΑ
Ανώνυμη Εταιρία (SA) · ATHENS, Greece · LEI 549300DQVDF0LKKQ2540
LEI active
Summary
JANSSEN-CILAG ΦΑΡΜΑKEYTIKH ΜΟΝΟΠΡΟΣΩΠΗ ΑΝΩΝΥΜΟΣ ΕΜΠΟΡΙΚΗ ΚΑΙ ΒΙΟΜΗΧΑΝΙΚΗ ΕΤΑΙΡΕΙΑ is registered in Greece and entered in the “General Commercial Registry (G.E.MI.)” under number 000314201000. Its legal form is Ανώνυμη Εταιρία (SA) – public limited company (Greece). According to GLEIF, its ultimate parent is Johnson & Johnson (United States), which is also its direct parent. That group has 209 subsidiaries with LEIs in 47 countries, 2 of them in Greece. The LEI was first issued on 6 Feb 2019 and the record was last updated on 15 Jul 2026; the next renewal is due by 15 Aug 2027. AssetCensus found 1 data-quality note for this entity (see below).
Written from GLEIF data using fixed, reviewed sentence templates.
Data-quality notes (AssetCensus analysis)
- The ultimate-parent link rests on accounts for the period ending 2 Jan 2023, more than 24 months before this data release. The group may have changed since.
Company details
| Legal form | Ανώνυμη Εταιρία (SA) public limited company (Greece) |
|---|---|
| Register | General Commercial Registry (G.E.MI.) · Register website |
| Registration number | 000314201000 |
| Registration authority | Union of Hellenic Chambers |
| Jurisdiction | Greece |
| Registered address | LEOF. IRINIS 56, LYKOVRYSI-PEFKI, 15121 ATHENS, Greece |
| Category | company or other legal entity |
| Status | active |
| Founded (per GLEIF) | 2 Jan 1979 |
| LEI | 549300DQVDF0LKKQ2540 |
| LEI status | active |
| LEI first issued | 6 Feb 2019 |
| LEI record last updated | 15 Jul 2026 |
| Next LEI renewal | 15 Aug 2027 |
| Corroboration of the LEI record | fully corroborated |
Group membership
JANSSEN-CILAG ΦΑΡΜΑKEYTIKH ΜΟΝΟΠΡΟΣΩΠΗ ΑΝΩΝΥΜΟΣ ΕΜΠΟΡΙΚΗ ΚΑΙ ΒΙΟΜΗΧΑΝΙΚΗ ΕΤΑΙΡΕΙΑ this entity
Relationship to the parent
| Direct parent | Ultimate parent | |
|---|---|---|
| Parent | Johnson & Johnson | Johnson & Johnson |
| Accounting period | 3 Jan 2022 to 2 Jan 2023 | 3 Jan 2022 to 2 Jan 2023 |
| Evidence | other official documents | other official documents |
| Corroboration | supplied by the entity only | supplied by the entity only |
| Accounting standard | US GAAP | US GAAP |
| Relationship start | 5 Feb 2019 | 5 Feb 2019 |
| Recorded at GLEIF since | 28 Dec 2023 | 28 Dec 2023 |
| Last updated | 29 Jul 2025 | 29 Jul 2025 |
| Record status | current | current |
Other subsidiaries of the same direct parent (97)
- (強生(香港)有限公司) Hong Kong
- ACCLARENT, INC. United States
- ACTELION PHARMACEUTICALS US, INC. United States lapsed
- ACTELION TREASURY UNLIMITED COMPANY Ireland
- ALZA CORPORATION United States
- AMO HOLDINGS, INC. United States lapsed
- AMO SALES AND SERVICE, INC. United States
- AURIS HEALTH, INC. United States
- BEIJING DABAO COSMETICS CO., LTD. China lapsed
- BIOMEDICAL ENTERPRISES, INC. United States lapsed
- BIOSENSE WEBSTER, INC. United States
- Cilag Holding AG Switzerland
Other names
- JANSSEN-CILAG ΦΑΡΜΑKEYTIKH ΑΝΩΝΥΜΟΣ ΕΜΠΟΡΙΚΗ ΚΑΙ ΒΙΟΜΗΧΑΝΙΚΗ ΕΤΑΙΡΕΙΑ · previous name
- JANSSEN - CILAG · trading name
- JOHNSON & JOHNSON INNOVATIVE MEDICINE · trading name
History
20 May 2024Legal name changed